Myriad Genetics Shares Outstanding 2006-2019 | MYGN

Myriad Genetics shares outstanding from 2006 to 2019. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
Myriad Genetics Annual Shares Outstanding
(Millions of Shares)
2019 76
2018 72
2017 69
2016 73
2015 75
2014 78
2013 83
2012 86
2011 92
2010 99
2009 99
2008 93
2007 86
2006 73
2005 61
Myriad Genetics Quarterly Shares Outstanding
(Millions of Shares)
Q1 2019 74
Q4 2019 76
Q3 2019 75
Q2 2018 77
Q1 2018 73
Q4 2018 72
Q3 2018 72
Q2 2017 72
Q1 2017 70
Q4 2017 69
Q3 2017 68
Q2 2016 68
Q1 2016 69
Q4 2016 73
Q3 2016 74
Q2 2015 74
Q1 2015 72
Q4 2015 75
Q3 2015 74
Q2 2014 75
Q1 2014 76
Q4 2014 78
Q3 2014 76
Q2 2013 77
Q1 2013 82
Q4 2013 83
Q3 2013 82
Q2 2012 84
Q1 2012 84
Q4 2012 86
Q3 2012 86
Q2 2011 86
Q1 2011 87
Q4 2011 92
Q3 2011 90
Q2 2010 94
Q1 2010 95
Q4 2010 99
Q3 2010 100
Q2 2009 99
Q1 2009 99
Q4 2009 99
Q3 2009 100
Q2 2008 98
Q1 2008 97
Q4 2008 93
Q3 2008 89
Q2 2007 88
Q1 2007 87
Q4 2007 86
Q3 2007 83
Q2 2006 80
Q1 2006 79
Q4 2006 73
Q3 2006 78
Q2 2005 71
Q1 2005 62
Q4 2005 61
Q3 2005 61
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $1.869B $0.851B
Myriad Genetics, Inc. is focused on revolutionizing patient care through the discovery, development and marketing of transformative molecular diagnostic tests that address pressing clinical needs across multiple medical specialties. Myriad is the pioneer and leader in molecular diagnostics, offering innovative products that transform patients' lives. These products include leading molecular diagnostic tests for hereditary cancer, urological cancer, lung cancer, autoimmune disorders and other diseases. Myriad has invested heavily in educating patients and healthcare professionals about the role genes and proteins play in disease. Myriad's hereditary cancer genetic testing, which helps healthcare professionals better manage and tailor medical care. Myriad is expanding their reach and increasing their impact on patient care by introducing new molecular diagnostic and companion diagnostic tests for a growing number of diseases.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $133.394B 15.37
CSL (CSLLY) Australia $84.649B 0.00
Gilead Sciences (GILD) United States $82.234B 10.19
Celgene (CELG) United States $76.958B 10.99
Vertex Pharmaceuticals (VRTX) United States $55.287B 56.43
Biogen (BIIB) United States $51.504B 8.84
Illumina (ILMN) United States $45.718B 50.16
Regeneron Pharmaceuticals (REGN) United States $37.820B 16.56
Actelion (ALIOF) Switzerland $29.891B 0.00
Alexion Pharmaceuticals (ALXN) United States $24.486B 12.09
Seattle Genetics (SGEN) United States $20.203B 0.00
Incyte (INCY) United States $18.942B 43.97
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $17.938B 0.00
BioMarin Pharmaceutical (BMRN) United States $13.962B 0.00
Genmab (GNMSF) Denmark $13.799B 60.95
Alnylam Pharmaceuticals (ALNY) United States $10.918B 0.00
Exact Sciences (EXAS) United States $10.880B 0.00
Bio-Rad Laboratories (BIO.B) United States $10.393B 49.88
Galapagos (GLPG) Belgium $10.106B 26.04
BeiGene (BGNE) Cayman Islands $9.682B 0.00
QIAGEN (QGEN) Netherlands $9.255B 30.18
Bio-Techne Corp (TECH) United States $8.245B 55.19
Amarin (AMRN) Ireland $8.119B 0.00
Guardant Health (GH) United States $7.358B 0.00
Sarepta Therapeutics (SRPT) United States $7.308B 0.00
ACADIA Pharmaceuticals (ACAD) United States $7.210B 0.00
Moderna (MRNA) United States $6.452B 0.00
Reata Pharmaceuticals (RETA) United States $6.202B 0.00
Horizon Therapeutics Public (HZNP) Ireland $5.713B 14.52
Medicines (MDCO) United States $5.597B 0.00
ARGENX SE-ADR (ARGX) Netherlands $5.588B 0.00
Exelixis (EXEL) United States $5.023B 14.13
Ascendis Pharma (ASND) Denmark $4.781B 0.00
China Biologic Products (CBPO) China $4.593B 25.87
Repligen (RGEN) United States $4.511B 81.75
Spark Therapeutics (ONCE) United States $4.289B 0.00
Bluebird Bio (BLUE) United States $4.094B 0.00
Blueprint Medicines (BPMC) United States $3.795B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $3.779B 0.00
Mirati Therapeutics (MRTX) United States $3.776B 0.00
MorphoSys AG (MOR) Germany $3.661B 0.00
Immunomedics (IMMU) United States $3.623B 0.00
Adaptive Biotechnologies (ADPT) United States $3.587B 0.00
Alkermes (ALKS) Ireland $3.143B 0.00
Genmab (GMAB) Denmark $2.907B 5.99
Halozyme Therapeutics (HALO) United States $2.806B 0.00
Intercept Pharmaceuticals (ICPT) United States $2.800B 0.00
Emergent Biosolutions (EBS) United States $2.793B 27.75
MyoKardia (MYOK) United States $2.597B 0.00
NeoGenomics (NEO) United States $2.529B 134.56
Amicus Therapeutics (FOLD) United States $2.487B 0.00
UniQure (QURE) Netherlands $2.399B 0.00
Arena Pharmaceuticals (ARNA) United States $2.311B 5.38
Acceleron Pharma (XLRN) United States $2.293B 0.00
Zai Lab (ZLAB) China $2.243B 0.00
RA PHARMCTL INC (RARX) United States $2.198B 0.00
Ultragenyx Pharmaceutical (RARE) United States $2.166B 0.00
Cambrex (CBM) United States $2.018B 25.46
Insmed (INSM) United States $1.846B 0.00
Ligand Pharmaceuticals (LGND) United States $1.823B 35.06
Akcea Therapeutics (AKCA) United States $1.792B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.642B 0.00
Momenta Pharmaceuticals (MNTA) United States $1.539B 0.00
Denali Therapeutics (DNLI) United States $1.534B 0.00
Zymeworks (ZYME) Canada $1.508B 0.00
Epizyme (EPZM) United States $1.461B 0.00
REGENXBIO (RGNX) United States $1.406B 0.00
Coherus BioSciences (CHRS) United States $1.375B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.328B 0.00
Editas Medicine (EDIT) United States $1.281B 0.00
Innoviva (INVA) United States $1.265B 3.73
Athenex (ATNX) United States $1.203B 0.00
Zealand Pharma (ZLDPF) Denmark $1.185B 0.00
Sangamo Therapeutics (SGMO) United States $1.122B 0.00
Arvinas (ARVN) United States $1.105B 0.00
WAVE Life Sciences (WVE) Singapore $1.101B 0.00
Fate Therapeutics (FATE) United States $1.096B 0.00
Alector (ALEC) United States $1.067B 0.00
Zealand Pharma (ZEAL) Denmark $1.038B 0.00
Orchard Therapeutics (ORTX) United Kingdom $1.011B 0.00
Principia Biopharma (PRNB) United States $0.983B 0.00
Cara Therapeutics (CARA) United States $0.897B 0.00
Achillion Pharmaceuticals (ACHN) United States $0.879B 0.00
Codexis (CDXS) United States $0.875B 0.00
Anika Therapeutics (ANIK) United States $0.858B 27.84
ZIOPHARM Oncology Inc (ZIOP) United States $0.840B 0.00
Vericel (VCEL) United States $0.828B 308.83
Vanda Pharmaceuticals (VNDA) United States $0.826B 6.95
BAVARIAN NORDIC (BVNRY) Denmark $0.791B 0.00
Pharming Group (PHGUF) Netherlands $0.753B 0.00
Intellia Therapeutics (NTLA) United States $0.732B 0.00
Revance Therapeutics (RVNC) United States $0.731B 0.00
Heska (HSKA) United States $0.718B 183.44
Twist Bioscience (TWST) United States $0.713B 0.00
ANI Pharmaceuticals (ANIP) United States $0.684B 11.66
DBV Technologies S.A (DBVT) France $0.674B 0.00
MiMedx (MDXG) United States $0.659B 0.00
Precision BioSciences (DTIL) United States $0.637B 0.00
Adverum Biotechnologies (ADVM) United States $0.621B 0.00
Mesoblast (MESO) Australia $0.604B 0.00
Agenus (AGEN) United States $0.599B 0.00
UROGEN PHARMA (URGN) United States $0.589B 0.00
GENFIT S.A (GNFT) France $0.585B 0.00
Cellectis S.A (CLLS) France $0.561B 0.00
Retrophin (RTRX) United States $0.556B 0.00
BioDelivery Sciences (BDSI) United States $0.551B 0.00
Cytokineticsorporated (CYTK) United States $0.547B 0.00
Kadmon Holdings (KDMN) United States $0.538B 0.00
Stemline Therapeutics (STML) United States $0.533B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.509B 0.00
AC Immune SA (ACIU) Switzerland $0.504B 11.66
Intra-Cellular Therapies (ITCI) United States $0.497B 0.00
Dynavax Technologies (DVAX) United States $0.495B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.493B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.479B 0.00
Sinovac Biotech (SVA) China $0.460B 0.00
PHARMA MAR SA (PHMMF) Spain $0.440B 0.00
Prothena (PRTA) Ireland $0.431B 0.00
Clovis Oncology (CLVS) United States $0.427B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.388B 2.68
Bellus Health (BLU) Canada $0.386B 0.00
Merus (MRUS) Netherlands $0.365B 0.00
PDL BioPharma (PDLI) United States $0.352B 8.80
Cellular Biomedicine (CBMG) United States $0.347B 0.00
Arcus Biosciences (RCUS) United States $0.347B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.328B 0.00
Puma Biotechnology (PBYI) United States $0.327B 0.00
Starpharma Holdings (SPHRY) Australia $0.322B 0.00
AnaptysBio (ANAB) United States $0.300B 0.00
Compugen (CGEN) Israel $0.298B 0.00
Avid Bioservices (CDMO) United States $0.294B 0.00
Kindred Biosciences (KIN) United States $0.293B 0.00
Protagonist Therapeutics (PTGX) United States $0.289B 0.00
Pfenex (PFNX) United States $0.285B 0.00
Gritstone Oncology (GRTS) United States $0.284B 0.00
Cel-Sci (CVM) United States $0.271B 0.00
Seres Therapeutics (MCRB) United States $0.262B 0.00
Theratechnologies (THTX) Canada $0.262B 0.00
Geron (GERN) United States $0.261B 0.00
Sutro Biopharma (STRO) United States $0.259B 0.00
OSMOTICA PHARM (OSMT) United States $0.258B 0.00
ADMA Biologics Inc (ADMA) United States $0.255B 0.00
Scholar Rock Holding (SRRK) United States $0.245B 0.00
MannKind (MNKD) United States $0.244B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.241B 0.00
Kamada (KMDA) Israel $0.240B 7.00
Inovio Pharmaceuticals (INO) United States $0.237B 0.00
Albireo Pharma (ALBO) United States $0.236B 0.00
CytomX Therapeutics (CTMX) United States $0.235B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.232B 0.00
XOMA (XOMA) United States $0.228B 0.00
Athersys (ATHX) United States $0.222B 0.00
Cue Biopharma (CUE) United States $0.220B 0.00
POXEL SA FRANCE (PXXLF) France $0.213B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.208B 0.00
Syros Pharmaceuticals (SYRS) United States $0.208B 0.00
ChromaDex (CDXC) United States $0.207B 0.00
Sorrento Therapeutics (SRNE) United States $0.203B 0.00
Biofrontera AG (BFRA) Germany $0.201B 0.00
Exicure (XCUR) United States $0.198B 0.00
Spero Therapeutics (SPRO) United States $0.191B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.188B 0.00
Arsanis (XFOR) United States $0.179B 0.00
Affimed (AFMD) Germany $0.178B 0.00
Palatin Technologies (PTN) United States $0.178B 4.85
CorMedix Inc (CRMD) United States $0.172B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.171B 0.00
Senesco Technologies (ELOX) United States $0.171B 0.00
Dyadic (DYAI) United States $0.171B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.150B 0.00
Cerecor (CERC) United States $0.148B 0.00
Alcobra (ARCT) United States $0.145B 0.00
Nicox SA (NICXF) France $0.141B 0.00
Enzo Biochem (ENZ) United States $0.135B 0.00
Fortress Biotech (FBIO) United States $0.132B 0.00
BioTime (LCTX) United States $0.128B 6.57
Northwest Biotherapeutics (NWBO) United States $0.128B 0.00
Mersana Therapeutics (MRSN) United States $0.125B 0.00
Ophthotech (ISEE) United States $0.124B 0.00
SESEN BIO, INC (SESN) United States $0.119B 0.00
Abeona Therapeutics (ABEO) United States $0.119B 0.00
Emmaus Life Sciences (EMMA) United States $0.118B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.118B 0.00
Five Prime Therapeutics (FPRX) United States $0.118B 0.00
Newron Pharmaceuticals SpA (NWPHF) Italy $0.117B 0.00
NantKwest (NK) United States $0.113B 0.00
Windtree Therapeutics (WINT) United States $0.113B 0.00
OvaScience (MLND) United States $0.110B 0.00
Celyad SA (CYAD) Belgium $0.109B 0.00
Aptinyx (APTX) United States $0.107B 0.00
VBI Vaccines (VBIV) United States $0.105B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.102B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.101B 0.00
Novavax (NVAX) United States $0.100B 0.00
Menlo Therapeutics (MNLO) United States $0.099B 0.00
PHASEBIO PHARMA (PHAS) United States $0.096B 0.00
Aduro Biotech (ADRO) United States $0.089B 0.00
Antibe Therapeutics (ATBPF) Canada $0.089B 0.00
Adocia (ADOCY) France $0.086B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.085B 0.00
Aquinox Pharmaceuticals (NLTX) United States $0.084B 0.00
Arbutus Biopharma (ABUS) Canada $0.084B 0.00
VTv Therapeutics (VTVT) United States $0.084B 0.00
Strongbridge Biopharma (SBBP) United States $0.081B 2.17
Acorda Therapeutics (ACOR) United States $0.076B 0.00
ARAVIVE, INC (ARAV) United States $0.076B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.072B 0.00
Selecta Biosciences (SELB) United States $0.068B 0.00
Vaccinex (VCNX) United States $0.068B 0.00
Synlogic (SYBX) United States $0.068B 0.00
Prima BioMed (IMMP) Australia $0.066B 0.00
Verastem (VSTM) United States $0.066B 0.00
Liquidia Technologies (LQDA) United States $0.064B 0.00
Organovo Holdings (ONVO) United States $0.064B 0.00
Trevena (TRVN) United States $0.063B 0.00
Catalyst Biosciences (CBIO) United States $0.062B 0.00
NewLink Genetics (NLNK) United States $0.060B 0.00
Idera Pharmaceuticals (IDRA) United States $0.059B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.059B 0.00
Checkpoint Therapeutics (CKPT) United States $0.058B 0.00
Proteostasis Therapeutics (PTI) United States $0.056B 0.00
Orgenesis (ORGS) United States $0.054B 3.50
Merrimack Pharmaceuticals (MACK) United States $0.053B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.053B 0.00
Applied Genetic Technologies (AGTC) United States $0.053B 0.00
China Health Industries Holdings (CHHE) China $0.052B 15.78
Pluristem Therapeutics (PSTI) Israel $0.050B 0.00
AIT Therapeutics (XAIR) United States $0.048B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.046B 0.00
Curis (CRIS) United States $0.046B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.046B 0.00
AquaBounty Technologies (AQB) United States $0.045B 0.00
DiaMedica Therapeutics (DMAC) United States $0.044B 0.00
Clearside Biomedical (CLSD) United States $0.043B 0.00
AmpliPhi Biosciences (ARMP) United States $0.042B 0.00
Vascular Biogenics (VBLT) Israel $0.041B 0.00
Evogene (EVGN) Israel $0.038B 0.00
Stellar Biotechnologies (EDSA) Canada $0.036B 0.00
Protalix BioTherapeutics (PLX) Israel $0.035B 0.00
Celldex Therapeutics (CLDX) United States $0.034B 0.00
Celsion (CLSN) United States $0.033B 0.00
Oncobiologics (OTLK) United States $0.031B 0.00
VIVUS (VVUS) United States $0.030B 0.00
INNOVATE BIOPHARMACEUTICALS, INC (INNT) United States $0.029B 0.00
Fibrocell Science Inc (FCSC) United States $0.029B 16.56
Caladrius Biosciences (CLBS) United States $0.029B 0.00
Entera Bio (ENTX) Israel $0.029B 0.00
Aptevo Therapeutics (APVO) United States $0.027B 0.00
Bionano Genomics (BNGO) United States $0.026B 0.00
BioCardia (BCDA) United States $0.026B 0.00
Alimera Sciences (ALIM) United States $0.026B 0.00
Apricus Biosciences (SEEL) United States $0.024B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.023B 0.00
Unum Therapeutics (UMRX) United States $0.021B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.021B 0.00
Signal Genetics (MGEN) United States $0.020B 0.00
Novogen (KZIA) Australia $0.020B 0.00
Soligenix (SNGX) United States $0.020B 0.00
AEterna Zentaris (AEZS) United States $0.019B 0.00
CollPlant Holdings (CLGN) Israel $0.019B 0.00
Pulmatrix (PULM) United States $0.016B 0.00
Aytu Bioscience (AYTU) United States $0.016B 0.00
Prana Biotechnology (ATHE) Australia $0.015B 0.00
VistaGen Therapeutics (VTGN) United States $0.014B 0.00
TOCAGEN INC (TOCA) United States $0.014B 0.00
MYOS RENS Technology (MYOS) United States $0.014B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.013B 0.00
IMMURON (IMRN) Australia $0.012B 0.00
TrovaGene (TROV) United States $0.011B 0.00
TRACON Pharmaceuticals (TCON) United States $0.010B 0.00
Cesca Therapeutics (THMO) United States $0.009B 0.00
Titan Pharmaceuticals (TTNP) United States $0.009B 0.00
Genetic Technologies (GENE) Australia $0.008B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.008B 0.00
Benitec Biopharma (BNTC) Australia $0.008B 0.00
Advaxis (ADXS) United States $0.007B 0.00
Cleveland BioLabs (CBLI) United States $0.006B 0.00
BioPharmX (BPMX) United States $0.004B 0.00
IBio (IBIO) United States $0.003B 0.00
Neuralstem (SNCA) United States $0.002B 0.00